GE HealthCare reported adjusted EPS of $0.99 for Q1 2026, below the $1.06 consensus, and adjusted EBIT of $691 million versus $734.5 million expected. Shares plunged 12.9%, touching a 52-week low of $58.75 after the profit shortfall.

Management cut full-year 2026 EPS guidance to a range of $4.80–$5.00, citing approximately $250 million in gross inflationary cost pressures related to memory chips, oil and freight. The company expects to offset more than half of these headwinds through pricing and cost optimization measures, with partial benefits in 2026 and larger savings in 2027.

The acquisition of Intelerad has been completed to strengthen its cloud-first enterprise imaging ecosystem, while a reorganization merged Imaging and Advanced Visualization into an 'Advanced Imaging Solutions' segment. Global demand remains robust, supported by a record equipment backlog of $21.8 billion.

New product introductions in imaging are slated to begin meaningful revenue contributions in the first half of 2027, aligning with typical order conversion timelines. The Patient Care Solutions segment is projected to improve in the second half of 2026, driven by large monitoring installations and a premium anesthesia product launch in Q3.